Date of Award
Chemistry & Biochemistry
Design of a novel isoxazoline class drug for the suppressive treatment of erythrocytic malaria through the inhibition of Plasmodium Falciparum Gylceraldehyde-3-phosphate Dehydrogenase (PfGAPDH) gave rise to creation of a synthetic plan for the proposed target molecule α-amino- 3-bromo-4,5-dihydroisoxazol-5-yl propionic acid. A literature-based analysis of the moieties targeting the PfGADPH active site led to the design of the target molecule. Subsequently, an exploration of the literature yielded a possible bifold synthetic plan. Attempts at a model epoxidation reaction using mCPBA and further efforts towards the synthesis of a 3- bromoisoxazoline were shown to be successful using GCMS analysis.
Ware, Peyton, "Design of a Novel Isoxazoline Class Drug for the Suppressive Treatment of Malaria" (2020). Honors Theses. 239.
Malaria--Treatment; Heterocyclic compounds; Isoxazolines.
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Files over 3MB may be slow to open. For best results, right-click and select "save as..."